Absorbable Nasal Implant Market - Forecast(2024 - 2030)

Absorbable Nasal Implant Market Overview

Absorbable Nasal Implant Market size is estimated to reach $770 million by 2026, growing at a CAGR of 7.1% during the forecast period 2021-2026. Absorbable nasal implants are utilized to back upper and lower lateral cartilage in the nose, strengthening the nasal wall like conventional cartilage and polymer grafts. The extensive adoption of absorbable nasal implants among consumers and the increasing utilization of absorbable nasal implants in cases of nasal valve collapse are driving the growth of the Absorbable Nasal Implant market. Carboxymethyl cellulose (CMC) or cellulose gum is a cellulose derivative with carboxymethyl groups (-CH 2 -COOH) constrained to some of the hydroxyl groups of the glucopyranose monomers that constitute the cellulose backbone. Carboxymethyl cellulose (CMC) is one of the materials used to prepare absorbable nasal implants. Sometimes the implants are polylactic acid copolymers. Absorbable Nasal Implants like LATERA are utilized to back the upper and lower lateral cartilage in the nose. The implant is established interior to the nasal wall in the least possible intrusive approach. Backing the cartilage in this way can decrease nasal airway obstruction symptoms and assist patients in improved respiration. Septoplasty is the most frequently carried out surgical technique to fix a diverged nasal septum and assist in the alleviation of nasal obstruction. At the time of septoplasty, the nasal septum is aligned and rearranged in the center of the nose. Absorbable nasal implants offer structural backing and smoothen the cartilage management at the time of nasal reconstruction techniques, and this is set to propel the growth of the Absorbable Nasal Implant Market during the forecast period 2021-2026. This represents the Absorbable Nasal Implant Market Industry Outlook.

Report Coverage

The report: “Absorbable Nasal Implant Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Absorbable Nasal Implant Market.

By Product Type: Drug-Eluting Implants (Corticosteroid Eluting Implants, Antibiotics Eluting Implants, Others), Non-Drug Eluting Implants.
By Material Type: Polymer Implant, Carboxymethylcellulose (CMC) Implant, Others.
By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers.
By Geography: North America (the U.S, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Rest of South America) and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America Absorbable Nasal Implant Market accounted for the highest revenue share in 2020 and it is poised to dominate the market over the period 2021-2026 owing to the considerable investments in research and development for effective treatment alternatives for issues like nasal airway obstruction with decreased side effects or requirement of secondary surgical techniques in the North American region.
• Absorbable Nasal Implant Market growth is driven by the health benefits like alleviation from nasal airway obstruction, the improved capability of breathing owing to cleared lateral nasal passage, and minimized difficulty in sleeping coupled with the rising acceptance for progressive implants by health professionals like doctors. However, binding regulatory directions, subconscious knowledge in the psyche about implant building discomfort, gentle ache, or irritability in few instances are acting as the major factors hampering the growth of the Absorbable Nasal Implant Market.
• Absorbable Nasal Implant Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Absorbable Nasal Implant Market report.
  
  

  Absorbable Nasal Implant Market Share (%) by Region, 2020
  

  

Absorbable Nasal Implant Market Segment Analysis – By Product Type:

The Absorbable Nasal Implant Market based on product type can be further segmented into Drug-Eluting Implants and Non-Drug Eluting Implants. The Drug-Eluting Implants Segment held the largest market share in 2020. The Drug-Eluting Implants segment is sub-segmented into Corticosteroid Eluting Implants, Antibiotics Eluting Implants, and Others This growth is owing to the extensive utilization of drug-eluting implants in nasal surgical treatments. Drug-eluting medical implants are active implants that encourage healing consequences, together with their typical task of backing. Drug-eluting implants provide productive regulated release of pharmaceuticals with compliance guaranteed. Furthermore, the Drug-Eluting segment is estimated to continue to grow with the fastest CAGR of 7.9% during the forecast period 2021-2026 owing to the great utilization in cases of nasal airway obstruction and nasal polyps.

Absorbable Nasal Implant Market Segment Analysis – By Material Type:

The Absorbable Nasal Implant Market based on the application can be further segmented into Polymer Implant, Carboxymethylcellulose (CMC) Implant, and Others. The Polymer segment held the largest market share in 2020. This growth is owing to the increasing utilization of Polymer material in the manufacture of absorbable nasal implants. The LATERA Nasal Implant is an ingenious and nominally intrusive kind of Nasal Airway Obstruction (NAO) treatment. The implant is tiny and prepared from PLLA (poly-L-lactide) polymer, which is planned to be absorbed by the nasal tissue. PLLA polymer is the industry standard for bioabsorbable implant material. This means that LATERA is a useful and secure technique to obtain alleviation from blocked airways. Furthermore, the Carboxymethylcellulose (CMC) Implant segment is estimated to grow with the fastest CAGR of 8.4% during the forecast period 2021-2026 owing to the increased utilization of Carboxymethylcellulose (CMC) nasal packing consequent to Functional endoscopic sinus surgery (FESS) in comparison with no packing.

Absorbable Nasal Implant Market Segment Analysis – By Geography:

The Absorbable Nasal Implant Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Absorbable Nasal Implant Market Market) held the largest share with 32% of the overall market in 2020. The growth of this region is owing to the increasing count of cases pertaining to nasal respiration like nasal airway obstruction and nasal valve collapse in the North American region. The presence of key players like Stryker Corporation in the U.S., the expanding investment in R&D for effective treatment alternatives with decreased side effects or requirement of secondary surgical techniques, and the advantages of absorbable nasal implants over non-absorbable nasal implants are fuelling the growth of the North American region. Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2021-2026. This growth is owing to factors like a big patient pool, acceptance of superior health care amenities, and heightening knowledge about advanced nasal reconstruction techniques among the users in the Asia-Pacific region. The rapid industrialization accompanied by associated air pollution may also lead to nasal respiration issues like nasal airway obstruction which is propelling the progress of the Absorbable Nasal Implant Market in the Asia-Pacific region.

Absorbable Nasal Implant Market Drivers

Increasing Count Of Cases With Nasal Breathing Issues Is Projected To Drive The Growth Of Absorbable Nasal Implant Market:

Nasal respiration transfers nearly 70% of airflow to the lungs. However, airway obstruction may restrict airflow by way of the nose. Over 20 million Americans are estimated to endure nasal airway obstruction (NAO), which restricts airflow by way of the nose with compelling quality of life results. Some signs of illness include nasal congestion or stuffiness, nasal blockage or obstruction, and difficulty in respiration by way of the nose. Even a little narrowing of the nasal valve may result in a considerable decrease in airflow. There are three typical kinds of structural blockage conditions namely septal deviation, turbinate hypertrophy, and nasal valve collapse. The LATERA® absorbable nasal implant is recommended for backing upper and lower lateral cartilage. The growing count of cases of nasal airway obstruction and nasal valve collapse are fuelling the growth of the Absorbable Nasal Implant Market during the forecast period 2021-2026.

Technological Innovations Are Expected To Boost The Demand Of The Absorbable Nasal Implant Industry:

Technological innovations are driving the growth of the Absorbable Nasal Implant Market. LATERA® developed by Stryker Corporation is an absorbable nasal implant utilized to back the upper and lower cartilage within the lateral (side) wall of the nose. Backing the cartilage can decrease nasal airway obstruction signs of illness and assist in better respiration. The implant is established within the nasal wall by an otolaryngologist (ear, nose, and throat [ENT] specialist) or facial plastic surgeon. The LATERA implant backs the upper and lower lateral cartilage by anchoring above the maxilla to offer cantilever backing. As per some LATERA® statistics on the LATERA website, 9/10 LATERA patients were pleased with the technique and 9/10 LATERA patients were pleased with their respiration after the technique. Furthermore, 9/10 patients were pleased with their appearance after the technique, as reported by more LATERA® statistics on the LATERA website. These kinds of innovations are propelling the growth of the Absorbable Nasal Implant Market during the forecast period 2021-2026.

Absorbable Nasal Implant Market Challenges

Binding Regulatory Guidelines, Instinctive Knowledge About Discomfort From Nasal Implants And Side-Effects Of Nasal Implants Are Challenging The Absorbable Nasal Implant Market:

Binding regulatory guidelines govern the application of absorbable nasal implants for the treatments of nasal breathing ailments. An example as cited: In May 2016, LATERA® (Stryker ENT, previously Spirox) was cleared for marketing by the U.S. Food and Drug Administration (FDA) through the 510(k) process.2, LATERA® is the only commercially available absorbable nasal implant for the treatment of nasal valve collapse. It is a class II device and regulatory details are summarized in the below Table:

Table. Absorbable Nasal Implant Cleared by the U.S. Food and Drug Administration

Sometimes patients are apprehensive about the discomfort they would experience if an absorbable nasal implant is placed within their nose. The utilization of an absorbable nasal implant like LATERA® may result in hazards like gentle bruising and inflammation, knowledge of the implant, and gentle ache or irritability. Additional hazards are inclusive of ache, infection, reaction to the material, and device retrieval. These issues are hampering the growth of the Absorbable Nasal Implant market.

Absorbable Nasal Implant Market Landscape:

Product launches, boost in clinical trials, strategic mergers and acquisitions, partnerships, collaborations, and R&D Activities are key strategies adopted by players in the Absorbable Nasal Implant Market. Key companies of this market include:

1. Intersect ENT, Inc.
2. Mentor Worldwide LLC (Johnson & Johnson)
3. Stryker Corporation
4. Allergan, Plc
5. Nagor
6. Implantech
7. Medartis AG
8. Acclarent, Inc. (Johnson & Johnson)
9. ArthroCare Corporation (Smith & Nephew, Inc.)
10. KLS Martin L.P.

Acquisitions/Product Launches:

• In September 2021, Acclarent, Inc., the portion of the Johnson & Johnson Medical Devices Companies, and chief in building minimally-intrusive Ear, Nose & Throat (ENT) technologies, declared the U.S. kick-off of its earliest ever AI (Artificial Intelligence)-powered ENT technology, constructed to ease surgical planning and offer real-time feedback at the time of ENT navigation techniques.
• In February 2021, one of the global chief medical technology firms, declared its EMEA kick-off of a wireless hospital bed, ProCuity™. This bed range was planned to assist in the decrease of in-hospital patient falls at all acuity levels and enhance nurse workflow effectiveness and security. It can link flawlessly to nurse call systems without the utilization of cables or wires.

Related Reports:

Dental Implants Market - Forecast(2021 - 2026)
Report Code: HCR 1300

Retinal Implant Market - Forecast(2021 - 2026)
Report Code: HCR 0370

For more Lifesciences and Healthcare related reports, please click here